Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

LianBio - news published 100 - readings 1.037

BACK

LianBio

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

11.04.2024

LianBio

Termination Notice - Form 15-12G

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-40947 LianBio (Exact name of registrant as ...

21.03.2024

LianBio

Notice of Effectiveness - Form EFFECT

Notice of Effectiveness UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: March 12, 2024 Accession Number: 0001628280-24-010378 Submission Type: POS AM CIK: 0001831283 Company Name: LianBio File Number: 333-268317 Attachments Original Link Permalink Disclaimer LianBio published this content on 12 March 2024 and ...

13.03.2024

LianBio

Post-effective Amendment to Registration Statement for Employee Benefit Plan - Form S-8 POS

Document As filed with the Securities and Exchange Commission on March 12, 2024 Registration No. 333-260732 Registration No. 333-264021 Registration No. 333-270913 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 (NO. 333-260732) POST-EFFECTIVE AMENDMENT NO. 1 (NO. 333-264021) POST-EFFECTIVE AMENDMENT NO. 1 (NO. 333-270913) ...

12.03.2024

LianBio

Post-effective Amendment to Registration Statement for Employee Benefit Plan - Form S-8 POS

12.03.2024

LianBio

Post-effective Amendment to Registration Statement for Employee Benefit Plan - Form S-8 POS

12.03.2024

LianBio

Post-Effective Amendment to Registration Statement - Form POS AM

Document As filed with the Securities and Exchange Commission on March 12, 2024 Registration No. 333-268317 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 (NO. 333-268317) TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LIANBIO (Exact name of registrant as specified in its charter) Cayman Islands 98-15 ...

12.03.2024

LianBio

Notice of Listing Removal - Form 25

The text version of this document is not available. You can access the original document here . Attachments Original Link Permalink Disclaimer LianBio published this content on 11 March 2024 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 11 March 2024 11:53:28 UTC .

11.03.2024

LianBio

LianBio Announces Voluntarily Delisting from Nasdaq

PDF Version SHANGHAI, China and PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN) ("LianBio" or the "Company"), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that it has provided notification to The Nasdaq Stock Market, Inc. ("Nasdaq") ...

28.02.2024

LianBio

Statement of Changes in Beneficial Ownership - Form 4

20.02.2024

LianBio

Statement of Changes in Beneficial Ownership - Form 4

20.02.2024

LianBio

LianBio Announces Completion of Strategic Review

PDF Version LianBio to commence the wind down of its operations, including sale of remaining assets and reduction in force, delisting from Nasdaq and issuance of special cash dividend SHANGHAI, China and PRINCETON, N.J., Feb. 13, 2024 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN) ("LianBio" or the "Company"), a biotechnology company dedicated to bringing innov ...

13.02.2024

LianBio

LianBio Announces Completion of Strategic Review - Form 8-K

LianBio Announces Completion of Strategic Review LianBio to commence the wind down of its operations, including sale of remaining assets and reduction in force, delisting from Nasdaq, and issuance of special cash dividend Shanghai and Princeton, NJ, February 13, 2024 - LianBio (Nasdaq: LIAN) ("LianBio" or the "Company"), a biotechnology company dedicated to ...

13.02.2024

LianBio

Initial Statement of Beneficial Ownership - Form 3

Ownership Submission FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per respo ...

26.12.2023

LianBio

Material Agreement - Form 8-K

Item 1.01 Entry into a Material Definitive Agreement. On December 22, 2023 (the "Closing Date"), LianBio Development (HK) Limited ("LianBio Development"), a subsidiary of LianBio, Janssen Pharmaceutica NV ("Janssen"), a Johnson & Johnson company, and, as applicable, LianBio entered into an Asset Purchase Agreement (the "APA"). LianBi ...

26.12.2023

LianBio - news published 100 - readings 1.037

LianBio

Statement of Changes in Beneficial Ownership - Form 4

LianBio

Termination Notice - Form 15-12G

LianBio

Notice of Effectiveness - Form EFFECT

LianBio

Post-effective Amendment to Registration Statement for Employee Benefit Plan - Form S-8 POS

LianBio

Post-effective Amendment to Registration Statement for Employee Benefit Plan - Form S-8 POS

LianBio

Post-effective Amendment to Registration Statement for Employee Benefit Plan - Form S-8 POS

LianBio

Post-Effective Amendment to Registration Statement - Form POS AM

LianBio

Notice of Listing Removal - Form 25

LianBio

LianBio Announces Voluntarily Delisting from Nasdaq

LianBio

Statement of Changes in Beneficial Ownership - Form 4

LianBio

Statement of Changes in Beneficial Ownership - Form 4

LianBio

LianBio Announces Completion of Strategic Review

LianBio

LianBio Announces Completion of Strategic Review - Form 8-K

LianBio

Initial Statement of Beneficial Ownership - Form 3

LianBio

Material Agreement - Form 8-K

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member